Pharmaceutical and Medical Device Industry Policy – Interaction with Industry Representatives
Adopted: May 22, 2007
Revised & Approved: November 15, 2007
Revised & Approved: December 15, 2009
Revised & Approved: October 18, 2011
Revised & Approved, January 21, 2014
Pharmaceutical and medical device representatives have an interest in making health care professionals aware of their products and new product developments. While interactions with sales representatives have a legitimate purpose, it is essential that information provided by these individuals is free of bias and financial inducements that might unduly influence medical decision making. The purpose of this policy is to define ethical standards for interacting with pharmaceutical and medical device manufacturers.